E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers S > Headlines for Sawai Pharmaceutical Co., Ltd. > News item
Published on 5/12/2011 in the Prospect News Convertibles Daily.

Sawai Pharmaceutical to cut conversion price on convertibles due 2015

By Marisa Wong

Madison, Wis., May 12 - Sawai Pharmaceutical Co., Ltd. gave notice that the conversion price of its ¥30 billion zero-coupon convertible bonds due 2015 will be adjusted on June 23, the approval date of a proposed dividend distribution.

The price will be adjusted to ¥9,497.8 share from ¥9,537 per share, effective retroactively to April 1.

Based in Osaka, Japan, Sawai Pharmaceutical specializes in generic drugs.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.